Sudarshan Pharma

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE00TV01023
  • NSEID: SUDARSHAN
  • BSEID: 543828
INR
29.76
-1.5 (-4.8%)
BSENSE

Nov 20

BSE+NSE Vol: 12079

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Jayant Agro Org.
Fairchem Organic
Valiant Organics
Kronox Lab
Sunshield Chem.
Sudarshan Pharma
Amal
Chemcon Special.
Indo Amines
Gem Aromatics
Sacheerome
Why is Sudarshan Pharma Industries Ltd ?
1
Flat results in Sep 26
  • DPR(Y) Lowest at 0.00%
  • INTEREST(Q) Highest at Rs 10.36 cr
2
Stock is technically in a Mildly Bearish range
  • The technical trend has deteriorated from Mildly Bullish on 20-Nov-26
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sudarshan Pharma for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Sudarshan Pharma
28.28%
0.50
56.13%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
28.10%
EBIT Growth (5y)
47.89%
EBIT to Interest (avg)
1.98
Debt to EBITDA (avg)
6.06
Net Debt to Equity (avg)
2.00
Sales to Capital Employed (avg)
1.43
Tax Ratio
26.22%
Dividend Payout Ratio
0
Pledged Shares
23.26%
Institutional Holding
22.00%
ROCE (avg)
9.89%
ROE (avg)
14.86%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
25
Industry P/E
40
Price to Book Value
3.75
EV to EBIT
17.91
EV to EBITDA
16.65
EV to Capital Employed
1.92
EV to Sales
1.44
PEG Ratio
0.87
Dividend Yield
NA
ROCE (Latest)
10.71%
ROE (Latest)
14.86%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company
NET SALES(Latest six months)

At Rs 391.39 cr has Grown at 24.59%

PBT LESS OI(Q)

At Rs 8.87 cr has Grown at 48.4% (vs previous 4Q average

PBDIT(Q)

Highest at Rs 20.59 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 9.49%

PAT(Q)

At Rs 8.09 cr has Grown at 28.8% (vs previous 4Q average

-11What is not working for the Company
DPR(Y)

Lowest at 0.00%

INTEREST(Q)

Highest at Rs 10.36 cr

Loading Valuation Snapshot...
Here's what is working for Sudarshan Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 8.87 cr has Grown at 48.4% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 5.98 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Net Sales - Latest six months
At Rs 391.39 cr has Grown at 24.59%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 20.59 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 9.49%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit After Tax (PAT) - Quarterly
At Rs 8.09 cr has Grown at 28.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 6.28 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Here's what is not working for Sudarshan Pharma
Interest - Quarterly
At Rs 10.36 cr has Grown at 26.19%
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Interest - Quarterly
Highest at Rs 10.36 cr
in the last five quarters and Increased by 26.19 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Dividend Payout Ratio (DPR) - Annually
Lowest at 0.00%
in the last five years
MOJO Watch
Company is distributing lower proportion of profits generated as dividend

DPR (%)